Smithfield Trust’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Hold |
80
| – | – | ﹤0.01% | 939 |
|
|
2025
Q1 | $6K | Hold |
80
| – | – | ﹤0.01% | 941 |
|
|
2024
Q4 | $6K | Hold |
80
| – | – | ﹤0.01% | 954 |
|
|
2024
Q3 | $6K | Hold |
80
| – | – | ﹤0.01% | 917 |
|
|
2024
Q2 | $10K | Sell |
80
-245
| -75% | -$30.6K | ﹤0.01% | 815 |
|
|
2024
Q1 | $46K | Hold |
325
| – | – | ﹤0.01% | 576 |
|
|
2023
Q4 | $40K | Buy |
325
+165
| +103% | +$20.3K | ﹤0.01% | 582 |
|
|
2023
Q3 | $15K | Hold |
160
| – | – | ﹤0.01% | 740 |
|
|
2023
Q2 | $20K | Hold |
160
| – | – | ﹤0.01% | 693 |
|
|
2023
Q1 | $19K | Hold |
160
| – | – | ﹤0.01% | 673 |
|
|
2022
Q4 | $19K | Hold |
160
| – | – | ﹤0.01% | 656 |
|
|
2022
Q3 | $12K | Hold |
160
| – | – | ﹤0.01% | 733 |
|
|
2022
Q2 | $12K | Hold |
160
| – | – | ﹤0.01% | 774 |
|
|
2022
Q1 | $20K | Hold |
160
| – | – | ﹤0.01% | 700 |
|
|
2021
Q4 | $21K | Hold |
160
| – | – | ﹤0.01% | 700 |
|
|
2021
Q3 | $21K | Hold |
160
| – | – | ﹤0.01% | 702 |
|
|
2021
Q2 | $17K | Hold |
160
| – | – | ﹤0.01% | 726 |
|
|
2021
Q1 | $14K | Hold |
160
| – | – | ﹤0.01% | 769 |
|
|
2020
Q4 | $15K | Sell |
160
-2,080
| -93% | -$195K | ﹤0.01% | 732 |
|
|
2020
Q3 | $231K | Hold |
2,240
| – | – | 0.02% | 259 |
|
|
2020
Q2 | $227K | Buy |
2,240
+1,200
| +115% | +$122K | 0.02% | 255 |
|
|
2020
Q1 | $70K | Buy |
+1,040
| New | +$70K | 0.01% | 390 |
|